Trials / Completed
CompletedNCT02657655
Kinesia 360 Parkinson's Monitoring Study
Kinesia 360 Multi-Center Parkinson's Monitoring Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Great Lakes NeuroTechnologies Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.
Detailed description
This is a five-month study of 45 subjects (approximately 15 subjects per site), consisting of adult volunteers that have been clinically diagnosed with Parkinson's disease. Subjects will have a confirmed history of motor fluctuation with a variety of Parkinson's disease symptom severities. All subjects will user the Kinesia 360 system and complete motor diaries several times per month during the study period. Symptom reports will be provided to the treating clinical team. Motor function, quality of life, engagement, and satisfaction with care will be tracked throughout the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Kinesia 360 | Kinesia 360 includes a mobile app and wireless motion sensors worn on the patient's wrist and ankle to quantify tremor, dyskinesias, and mobility throughout the day as he or she goes about normal activities. The app includes electronic diaries enable patients to rate their symptoms and log when medications are taken. Data is transferred to a cloud server where motor symptom reports are generated for clinician review. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-01-18
- Last updated
- 2018-02-19
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02657655. Inclusion in this directory is not an endorsement.